Condition
Acute Coronary Syndromes clinical trials and research
As of November 12, 2026, Find a Trial lists 19 Acute Coronary Syndromes clinical trials that are recruiting, at sites in 20 countries (most in China (3), Italy (3), Switzerland (2)). By phase: Phase 4 (3), Phase 3 (1), Phase 2 (1), Early Phase 1 (1). There are also 1 NIH-funded research project on Acute Coronary Syndromes, with $668,630 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 19Clinical trials
- 1NIH research projects
- 20Countries
Newest Acute Coronary Syndromes clinical trials
All recruiting trials (19)
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Early Triple Lipid-Lowering Therapy After ACS
This trial tests whether adding bempedoic acid to high-intensity statin and ezetimibe within 72 hours after PCI helps more adults with acute coronary syndrome reach LDL-C goals than the standard two-drug approach.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Early single antiplatelet therapy after IVUS-guided PCI in ACS
This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.
-
Local and systemic macrophage activation in coronary and peripheral artery disease
This study tests whether macrophage activity inside coronary and peripheral arteries relates to circulating monocyte subtypes in people with stable and acute artery disease.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
-
Coronary Laser Atherectomy Registry in an International Network
This registry tests how well Excimer Laser Coronary Atherectomy (ELCA) works in real-world PCI for people with stable or acute coronary conditions across multiple countries.
-
Hand fan to prevent ticagrelor-related breathlessness
This study will try to see if using a handheld fan can reduce breathing discomfort in adults with acute coronary syndrome who are starting ticagrelor.
-
Oregano and basil leaves for people with unstable angina
This project will see if eating more oregano and basil reduces inflammation and improves blood lipid and urine polyphenol levels in people who recently had unstable angina.
-
Understanding the connection between stroke and heart issues
This study is trying to understand how strokes affect heart health and overall well-being in stroke patients to find new ways to help them recover better.
-
Orticumab to reduce coronary artery inflammation after a heart attack
This tests whether orticumab can reduce coronary artery inflammation over six months in people who had a heart attack and show high inflammation on coronary CT angiography.
-
Assessing the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes
This study is testing if measuring blood vessel response can help predict outcomes for patients with serious heart conditions like heart attacks.
-
Testing UDP-003 for safety and effectiveness in healthy individuals and patients with heart conditions
This study is testing a new drug called UDP-003 to see if it's safe and effective for both healthy people and those with heart conditions, specifically looking at its ability to reduce plaque buildup in the arteries.
-
Comparing Atorvastatin and Rosuvastatin's effects on Vitamin D levels in heart patients
This study tests whether taking Atorvastatin or Rosuvastatin affects Vitamin D levels in heart patients with acute coronary syndrome.
-
National registry for heart attacks in young adults in Serbia
This study looks at heart attacks in young adults under 45 in Serbia to see what causes them and how to improve treatment and prevention.
-
Evaluating early lipid-lowering therapy in acute coronary syndrome patients
This study is testing if starting a new cholesterol-lowering treatment early can help Chinese patients with acute coronary syndrome have better heart health and lower cholesterol levels compared to other treatments.
-
Home-based cardiac rehabilitation with family empowerment for people after acute coronary syndrome
This program will test whether a home-based cardiac rehab plan that trains and involves family members helps adults recovering from acute coronary syndrome improve exercise capacity and quality of life.
-
Using low-dose IL-2 to reduce vascular inflammation in heart attack patients
This study is trying to see if low-dose IL-2 can help heart attack patients by reducing inflammation and preventing serious heart problems after their initial treatment.
-
Registry of Acute Coronary Syndromes in Ferrara
This study is collecting information about how patients with acute coronary syndromes are treated in Ferrara, Italy, to better understand their care and outcomes.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Polypill approach after a heart attack to simplify and improve aftercare
A research study will test a single combined pill to help people take their post-heart-attack medicines reliably.
Related topics
Quick answers
How many Acute Coronary Syndromes clinical trials are recruiting right now?
19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in China (3 trials), Italy (3 trials), Switzerland (2 trials), Spain (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 3: 1, Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.